Michael Schmidt Stock Analyst Profile - Guggenheim Research Coverage - Stocknear

Michael Schmidt

Stock Analyst at Guggenheim

(5)
# 244
Out of 5,506 analysts
163
Total ratings
Success rate
Average return

55 Stocks

Name Action PT Current % Upside Ratings Updated
GMAB Genmab
Upgrades: Buy
43
33.56 28.13% 3 Sep 23, 2025
INCY Incyte
Reiterates: Neutral
n/a
n/a n/a 6 Sep 19, 2025
IMNM Immunome
Reiterates: Buy
25 25
12.38 101.94% 3 Aug 25, 2025
MRSN Mersana Therapeutics
Maintains: Buy
125 30
8.28 262.32% 4 Aug 14, 2025
ADCT ADC Therapeutics
Reiterates: Buy
10 10
4.08 145.1% 6 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
11.56 55.71% 6 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
10 12
3.7 224.32% 5 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
350 365
343.87 6.14% 4 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 15
9.61 56.09% 6 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 10
7.76 28.87% 1 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
17 17
15.76 7.87% 1 Jul 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
46.71 71.27% 4 Jun 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
19.84 126.81% 2 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 15
17.4 -13.79% 1 May 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
52 52
57.9 -10.19% 1 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
47 47
n/a n/a 3 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 10
5.48 82.48% 1 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32 32
15.6 105.13% 3 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
20.51 -60.99% 2 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 109
94.29 15.6% 5 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 2
n/a n/a 3 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
8.7 60.92% 3 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
42 42
40.09 4.76% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 1 Jan 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
4.96 303.23% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
1.61 396.89% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7
0.83 743.37% 4 Sep 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 345
n/a n/a 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 31
n/a n/a 1 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 34
11.77 188.87% 4 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
104 60
n/a n/a 10 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
170
n/a n/a 3 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
2.42 933.06% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
7.74 287.6% 1 Jul 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
4.63 461.56% 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 39
n/a n/a 1 Apr 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 27, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 48
n/a n/a 2 Dec 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 5, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80
40.5 97.53% 4 Feb 15, 2019